| pubmed-article:21888027 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C0080279 | lld:lifeskim |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C1412097 | lld:lifeskim |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C0023473 | lld:lifeskim |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C0000744 | lld:lifeskim |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C0031727 | lld:lifeskim |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C1826328 | lld:lifeskim |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C1514562 | lld:lifeskim |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C1883221 | lld:lifeskim |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C0683598 | lld:lifeskim |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C2266681 | lld:lifeskim |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C1268567 | lld:lifeskim |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C2757011 | lld:lifeskim |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C0868928 | lld:lifeskim |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C0021201 | lld:lifeskim |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C1883204 | lld:lifeskim |
| pubmed-article:21888027 | lifeskim:mentions | umls-concept:C1880389 | lld:lifeskim |
| pubmed-article:21888027 | pubmed:issue | 7-8 | lld:pubmed |
| pubmed-article:21888027 | pubmed:dateCreated | 2011-9-5 | lld:pubmed |
| pubmed-article:21888027 | pubmed:abstractText | The current study was undertaken to find out the frequency and distribution of ABL kinase domain (KD) mutations showing resistance to tyrosine kinase inhibitors (TKI) in CML patients from India. | lld:pubmed |
| pubmed-article:21888027 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21888027 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21888027 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21888027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21888027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21888027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21888027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21888027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21888027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21888027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21888027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21888027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21888027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21888027 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21888027 | pubmed:issn | 1433-6510 | lld:pubmed |
| pubmed-article:21888027 | pubmed:author | pubmed-author:SaikiaTapanT | lld:pubmed |
| pubmed-article:21888027 | pubmed:author | pubmed-author:DasBibhuB | lld:pubmed |
| pubmed-article:21888027 | pubmed:author | pubmed-author:BagadiSaritaS | lld:pubmed |
| pubmed-article:21888027 | pubmed:author | pubmed-author:PanyAyaskantA | lld:pubmed |
| pubmed-article:21888027 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:21888027 | pubmed:volume | 57 | lld:pubmed |
| pubmed-article:21888027 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21888027 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21888027 | pubmed:pagination | 619-23 | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:meshHeading | pubmed-meshheading:21888027... | lld:pubmed |
| pubmed-article:21888027 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21888027 | pubmed:articleTitle | Analysis of ABL kinase domain mutations conferring resistance to tyrosine kinase inhibitors in chronic myeloid leukemia cases from India. | lld:pubmed |
| pubmed-article:21888027 | pubmed:affiliation | Research and Development, Super Religare Laboratories, Mumbai, India. | lld:pubmed |
| pubmed-article:21888027 | pubmed:publicationType | Journal Article | lld:pubmed |
| entrez-gene:25 | entrezgene:pubmed | pubmed-article:21888027 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21888027 | lld:entrezgene |
